Polymicrobial and monomicrobial necrotizing soft tissue infections: comparison of clinical, laboratory, radiological, and pathological hallmarks and prognosis. A retrospective analysis.
fasciitis
intensive care
necrotizing
Journal
Trauma surgery & acute care open
ISSN: 2397-5776
Titre abrégé: Trauma Surg Acute Care Open
Pays: England
ID NLM: 101698646
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
04
2021
accepted:
14
09
2021
entrez:
25
10
2021
pubmed:
26
10
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Necrotizing soft tissue infection (NSTI) is a life-threatening infection associated with high morbidity and mortality. Treatment consists of surgery and antibiotics. Many studies have addressed NSTI and its subtypes, but few have reviewed the clinical, radiological, and pathological differences between the polymicrobial and monomicrobial diseases. The objective of our study was to evaluate the clinical, radiological, and pathological features of patients with polymicrobial (NSTI I) and monomicrobial (NSTI II) infections and their association with outcome. The cohort consisted of patients hospitalized with NSTI at a tertiary medical center in 2002-2019. The medical charts were reviewed for clinical, radiological, and pathological features. Findings were compared between patients in whom blood/tissue bacterial cultures yielded one or more than one pathological isolate. The primary clinical outcome measure of the study was all-cause mortality at 90 days. Secondary outcomes were duration of hospitalization, intensive care unit (ICU) admission, score on the LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis), and need for vasopressor treatment. A total of 81 patients met the inclusion criteria: 54 (66.6%) with monomicrobial NSTI and 27 (33.3%) with polymicrobial NSTI. There were no significant between-group differences in in-hospital and 90-day mortality. On multivariate analysis, the monomicrobial disease group had a significantly higher 90-day mortality rate in addition to higher rates of in-hospital mortality, ICU admission, and vasopressor use than the polymicrobial disease group. Our study is the first to compare the clinical, radiological, and pathological differences between the two most common types of NSTI. The results demonstrate better prognosis for polymicrobial NSTI, with minimal ICU stay, lower mortality, and lower use of vasopressors. Prognostic and epidemiological, level III.
Sections du résumé
BACKGROUND
BACKGROUND
Necrotizing soft tissue infection (NSTI) is a life-threatening infection associated with high morbidity and mortality. Treatment consists of surgery and antibiotics. Many studies have addressed NSTI and its subtypes, but few have reviewed the clinical, radiological, and pathological differences between the polymicrobial and monomicrobial diseases. The objective of our study was to evaluate the clinical, radiological, and pathological features of patients with polymicrobial (NSTI I) and monomicrobial (NSTI II) infections and their association with outcome.
METHODS
METHODS
The cohort consisted of patients hospitalized with NSTI at a tertiary medical center in 2002-2019. The medical charts were reviewed for clinical, radiological, and pathological features. Findings were compared between patients in whom blood/tissue bacterial cultures yielded one or more than one pathological isolate. The primary clinical outcome measure of the study was all-cause mortality at 90 days. Secondary outcomes were duration of hospitalization, intensive care unit (ICU) admission, score on the LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis), and need for vasopressor treatment.
RESULTS
RESULTS
A total of 81 patients met the inclusion criteria: 54 (66.6%) with monomicrobial NSTI and 27 (33.3%) with polymicrobial NSTI. There were no significant between-group differences in in-hospital and 90-day mortality. On multivariate analysis, the monomicrobial disease group had a significantly higher 90-day mortality rate in addition to higher rates of in-hospital mortality, ICU admission, and vasopressor use than the polymicrobial disease group.
CONCLUSION
CONCLUSIONS
Our study is the first to compare the clinical, radiological, and pathological differences between the two most common types of NSTI. The results demonstrate better prognosis for polymicrobial NSTI, with minimal ICU stay, lower mortality, and lower use of vasopressors.
LEVEL OF EVIDENCE
METHODS
Prognostic and epidemiological, level III.
Identifiants
pubmed: 34693024
doi: 10.1136/tsaco-2021-000745
pii: tsaco-2021-000745
pmc: PMC8499350
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e000745Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
ANZ J Surg. 2016 Oct;86(10):826-830
pubmed: 26211758
AJR Am J Roentgenol. 1998 Mar;170(3):615-20
pubmed: 9490940
Int J Infect Dis. 2014 Nov;28:13-6
pubmed: 25220388
Dermatology. 2004;209(1):64-5
pubmed: 15237272
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Am J Surg. 1977 Jul;134(1):52-7
pubmed: 327844
World J Emerg Surg. 2016 Aug 08;11:40
pubmed: 27508002
BMC Infect Dis. 2011 Oct 31;11:297
pubmed: 22040231
Clin Infect Dis. 2012 Oct;55(7):930-9
pubmed: 22715175
Clin Infect Dis. 2014 Jul 15;59(2):e10-52
pubmed: 24973422
J Trauma Acute Care Surg. 2012 Mar;72(3):560-6
pubmed: 22491537
J Am Coll Surg. 2000 Sep;191(3):227-31
pubmed: 10989895
Med Princ Pract. 2015;24(5):416-23
pubmed: 26066555
Int J Gen Med. 2015 May 14;8:195-202
pubmed: 25999758
Radiol Med. 2016 Feb;121(2):106-21
pubmed: 26286006
J Hosp Infect. 2010 Aug;75(4):249-57
pubmed: 20542593
Radiographics. 2007 Nov-Dec;27(6):1723-36
pubmed: 18025514
Clin Infect Dis. 2007 Oct 1;45(7):853-62
pubmed: 17806049
Crit Care Med. 2011 Sep;39(9):2156-62
pubmed: 21532474
J Acad Nutr Diet. 2019 Mar;119(3):375-393
pubmed: 29685825
Lancet. 1994 Oct 22;344(8930):1111-5
pubmed: 7934492
World J Emerg Surg. 2016 May 27;11:21
pubmed: 27239222
Crit Care Med. 2004 Jul;32(7):1535-41
pubmed: 15241098
N Engl J Med. 2017 Dec 7;377(23):2253-2265
pubmed: 29211672
South Med J. 2003 Sep;96(9):900-5
pubmed: 14513988
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
Int J Dermatol. 2007 Oct;46(10):1036-41
pubmed: 17910710
Epidemiol Infect. 2009 Nov;137(11):1609-14
pubmed: 19351432
Crit Care Med. 2017 Nov;45(11):1813-1819
pubmed: 28759474
Ann Surg. 1995 May;221(5):558-63; discussion 563-5
pubmed: 7748037
J Bone Joint Surg Am. 2003 Aug;85(8):1454-60
pubmed: 12925624
Epidemiol Infect. 2006 Apr;134(2):293-9
pubmed: 16490133
Arch Intern Med. 1985 Jun;145(6):1020-3
pubmed: 3890787
J Emerg Med. 2008 Feb;34(2):139-46
pubmed: 17976799